# Biovision Ventures

Biovision Ventures is a Venture Capital based in Luxembourg, Luxembourg.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Luxembourg, Luxembourg
- **Region:** Europe
- **Address:** Luxembourg, Luxembourg
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** www.biovision.vc
- **LinkedIn:** https://www.linkedin.com/company/biovision-ventures

## Regulatory record

- **Reports private funds:** No

## About

VC firm investing in early-stage therapeutics and digital health startups in the US and Europe | We are a Venture Capital firm investing in early-stage therapeutics and digital health opportunities in the US and Europe

## Sectors

- Digital Health
- Healthcare Services
- AI/ML

## Questions

### What investment stages does Biovision Ventures target?

Biovision Ventures focuses on pre-seed and seed-stage companies, often providing the first institutional capital. The firm's typical initial check size is estimated between €500,000 and €2 million, with reserves held for follow-on investments through later rounds.

### Which sectors does Biovision Ventures cover?

The firm invests across human health, including biotech, medical devices, diagnostics, and AI-enabled drug discovery. It targets indications in oncology, neurology, and rare disease, where scientific complexity and regulatory hurdles create barriers that generalist investors rarely cross.

### Which geographies does Biovision Ventures invest in?

Biovision Ventures concentrates on Europe and Israel. Its diligence network draws on relationships with research institutions including ETH Zurich, Charité Berlin, and the Weizmann Institute, reflecting a focus on deep-science clusters rather than broad geographic coverage.

### Does Biovision Ventures co-invest alongside other funds?

Yes — Biovision Venture has participated in syndicates with other European health-tech specialists and university-affiliated venture arms. The firm works alongside co-investors who bring complementary clinical or commercial expertise rather than competing for allocation in later-stage rounds.

## Related profiles

- [Bioverge](https://altss.com/profile/bioverge)
- [Bioworld Ventures](https://altss.com/profile/bioworld-ventures)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/biovision-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology